knowledge -WSS

knowledge

author：comprehensive 2025-08-11 02:16:12 - browse：49943

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve fatty liver disease, according to early clinical trial data the pharmaceutical company released Tuesday.

Eli Lilly reported during its fourth-quarter earnings call that tirzepatide, which is sold commercially as Mounjaro or Zepbound, succeeded in a Phase 2 test as a treatment for the liver disease MASH. Around 74% of adults in the trial taking the drug were free of MASH after 52 weeks, compared to approximately 13% of the placebo group.

MASH, formerly known as NASH, is a liver disease characterized by excess fat and inflammation. The chronic inflammation can also lead to liver scarring, or fibrosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Zapping the brain for stroke rehab: Pivotal clinical trial begins

knowledge

leisure time

WSS

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Radiation, mainstay of cancer treatment, begins a fade

How to make AI work for medicine

Radiation, mainstay of cancer treatment, begins a fade

Former Georgia lieutenant governor says he received grand jury subpoena

Appeals court upholds limits to abortion pill

leisure time

knowledge

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Lessons Learned: This is why you network to find that industry job you want

Tori Bowie and the unacceptable rates of Black maternal death

Germany receives 178 compensation applications from gay servicepeople over discrimination

23andMe had bad news about my health. I wish a person had delivered it

Radiation, mainstay of cancer treatment, begins a fade

Bright Health sells Medicare Advantage business to Molina

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Former Georgia lieutenant governor says he received grand jury subpoena

hotspot

The painfully weak evidence on taking collagen to treat arthritis

The painfully weak evidence on taking collagen to treat arthritis

Departing Stanford president retracts two papers

Winners, losers from Medicare’s list of drugs subject to price talks

2024 GOP presidential candidates spar over abortion in debate

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Wikipedia

knowledge

leisure time

entertainment